259 related articles for article (PubMed ID: 38094301)
1. The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.
Cao L; Xie W; Ma W; Zhao H; Wang J; Liang Z; Tian S; Wang B; Ma J
Front Immunol; 2023; 14():1238684. PubMed ID: 38094301
[TBL] [Abstract][Full Text] [Related]
2. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
3. Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
Foster JB; Griffin C; Rokita JL; Stern A; Brimley C; Rathi K; Lane MV; Buongervino SN; Smith T; Madsen PJ; Martinez D; Delaidelli A; Sorensen PH; Wechsler-Reya RJ; Karikó K; Storm PB; Barrett DM; Resnick AC; Maris JM; Bosse KR
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36167467
[TBL] [Abstract][Full Text] [Related]
4. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.
Mehani B; Asanigari S; Chung HJ; Dazelle K; Singh A; Hannenhalli S; Aldape K
Acta Neuropathol Commun; 2022 Feb; 10(1):19. PubMed ID: 35144680
[TBL] [Abstract][Full Text] [Related]
5. Characterization of distinct immunophenotypes across pediatric brain tumor types.
Griesinger AM; Birks DK; Donson AM; Amani V; Hoffman LM; Waziri A; Wang M; Handler MH; Foreman NK
J Immunol; 2013 Nov; 191(9):4880-8. PubMed ID: 24078694
[TBL] [Abstract][Full Text] [Related]
6. Adolescents and Young Adults With Cancer: CNS Tumors.
Wu J; Heidelberg RE; Gajjar A
J Clin Oncol; 2024 Feb; 42(6):686-695. PubMed ID: 38064656
[TBL] [Abstract][Full Text] [Related]
7. Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma.
Yan D; Li W; Liu Q; Yang K
Front Immunol; 2022; 13():914618. PubMed ID: 35769466
[TBL] [Abstract][Full Text] [Related]
8. Potential of IDH mutations as immunotherapeutic targets in gliomas: a review and meta-analysis.
Gonzalez N; Asad AS; Gómez Escalante J; Peña Agudelo JA; Nicola Candia AJ; García Fallit M; Seilicovich A; Candolfi M
Expert Opin Ther Targets; 2021 Dec; 25(12):1045-1060. PubMed ID: 34904924
[TBL] [Abstract][Full Text] [Related]
9. PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.
Hwang K; Koh EJ; Choi EJ; Kang TH; Han JH; Choe G; Park SH; Yearley JH; Annamalai L; Blumenschein W; Sathe M; McClanahan T; Jung H; Wang KC; Kim SK; Kim CY
J Neurooncol; 2018 Sep; 139(2):281-291. PubMed ID: 29730815
[TBL] [Abstract][Full Text] [Related]
10. Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma.
Tang F; Pan Z; Wang Y; Lan T; Wang M; Li F; Quan W; Liu Z; Wang Z; Li Z
Neurosci Bull; 2022 Sep; 38(9):1069-1084. PubMed ID: 35670952
[TBL] [Abstract][Full Text] [Related]
11. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
Berger TR; Wen PY; Lang-Orsini M; Chukwueke UN
JAMA Oncol; 2022 Oct; 8(10):1493-1501. PubMed ID: 36006639
[TBL] [Abstract][Full Text] [Related]
12. Pediatric brain tumor cell lines exhibit miRNA-depleted, Y RNA-enriched extracellular vesicles.
Magaña SM; Peterson TE; Evans JE; Decker PA; Simon V; Eckel-Passow JE; Daniels DJ; Parney IF
J Neurooncol; 2022 Jan; 156(2):269-279. PubMed ID: 34984645
[TBL] [Abstract][Full Text] [Related]
13. New insights into the Immune TME of adult-type diffuse gliomas.
Richard Q; Laurenge A; Mallat M; Sanson M; Castro-Vega LJ
Curr Opin Neurol; 2022 Dec; 35(6):794-802. PubMed ID: 36226710
[TBL] [Abstract][Full Text] [Related]
14. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.
Wang Z; Liu X; Wang Z; Bao Z; Zhang W; Zhang C; Jiang T
Curr Mol Med; 2018 Mar; 17(7):518-526. PubMed ID: 29437008
[TBL] [Abstract][Full Text] [Related]
16. mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors.
Trivedi V; Yang C; Klippel K; Yegorov O; von Roemeling C; Hoang-Minh L; Fenton G; Ogando-Rivas E; Castillo P; Moore G; Long-James K; Dyson K; Doonan B; Flores C; Mitchell DA
Genome Med; 2024 Jan; 16(1):17. PubMed ID: 38268001
[TBL] [Abstract][Full Text] [Related]
17. Implications of IDH mutations on immunotherapeutic strategies for malignant glioma.
Richardson LG; Miller JJ; Kitagawa Y; Wakimoto H; Choi BD; Curry WT
Neurosurg Focus; 2022 Feb; 52(2):E6. PubMed ID: 35104795
[TBL] [Abstract][Full Text] [Related]
18. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
Cacciotti C; Fleming A; Ramaswamy V
J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
[TBL] [Abstract][Full Text] [Related]
19. Mapping pediatric brain tumors to their origins in the developing cerebellum.
Okonechnikov K; Joshi P; Sepp M; Leiss K; Sarropoulos I; Murat F; Sill M; Beck P; Chan KC; Korshunov A; Sah F; Deng MY; Sturm D; DeSisto J; Donson AM; Foreman NK; Green AL; Robinson G; Orr BA; Gao Q; Darrow E; Hadley JL; Northcott PA; Gojo J; Kawauchi D; Hovestadt V; Filbin MG; von Deimling A; Zuckermann M; Pajtler KW; Kool M; Jones DTW; Jäger N; Kutscher LM; Kaessmann H; Pfister SM
Neuro Oncol; 2023 Oct; 25(10):1895-1909. PubMed ID: 37534924
[TBL] [Abstract][Full Text] [Related]
20. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
